Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04292002
Other study ID # IN-UK-276-5347 HIV DVE
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 17, 2019
Est. completion date May 31, 2021

Study information

Verified date September 2021
Source University of Nottingham
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This project is called Test@Work. In this project the investigators will offer general health checks and tailored health advice to up to 650 employees in the construction industry at sites across the East Midlands. The investigators will assess reach and uptake, and evaluate the views and perceptions of employees, managers and the delivery team. Health checks will include Body Mass Index (BMI; weight/height), waist-to-hip ratio, blood pressure, mental health screen, sexual health consultation and an opt-in rapid screening test for human immunodeficiency virus (HIV). Employees will be provided with a resource pack with information and signposting around physical activity, diabetes risk, diet, and musculoskeletal health. A digital resource providing information and signposting about workplace health screening and HIV testing will be developed and provided to managers at the participating worksites 2 weeks before their health check event. Employees will be offered an additional text messaging service involving receipt of a series of messages with advice around HIV and testing alongside general health information. Employees will complete post-health check exit questionnaires and an exit interview. Managers will complete a post-event evaluation questionnaire and post-event interview. Mixed-methods evaluation will include assessment of reach, uptake, and intervention implementation processes.


Description:

The investigators will collect evaluation data with employees and company representatives. Employees: will complete exit-questionnaires and be invited to a brief exit interview. The investigators will collect by anonymous questionnaire: age, gender, country of birth, ethnicity, postcode, sexual orientation, employment status (FT/PT, permanent, agency, contract worker), reasons for attending, health perceptions, prior HIV testing history, influence of work on health, perceptions of employers provision for health and wellbeing, perceptions towards HIV testing in the workplace, range of tests undertaken, views about the workplace health check and future health intentions. Personal identifiers will not be collected and questionnaire data will not be provided to employers. Those employees who agree to be interviewed after the health check will be invited to a brief independent confidential interview with the project researcher. Company representatives: will complete brief post-event questionnaire and be invited to post-event interview The investigators will ask about the organisational/employee profile, their perceptions of company provision for health and wellbeing, perceptions towards the usefulness of the implementation toolkit and towards HIV testing in the workplace, method of delivery and their confidence to support employees who disclose a positive test outcome, views about the workplace health check and future implementation intentions.


Recruitment information / eligibility

Status Completed
Enrollment 456
Est. completion date May 31, 2021
Est. primary completion date November 30, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - employee of a company in construction or related industries - provides informed consent Exclusion Criteria: - does not speak English

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Test@Work
Offer of a general health check including opt-in sexual health consultation and HIV testing, weight/height, Body Mass Index (BMI), blood pressure, mental health screen. Provision of tailored health advice and a resource pack with information and signposting.

Locations

Country Name City State
United Kingdom University of Nottingham Nottingham

Sponsors (1)

Lead Sponsor Collaborator
University of Nottingham

Country where clinical trial is conducted

United Kingdom, 

References & Publications (4)

Blake H, Somerset S, Evans C. Development and Fidelity Testing of the Test@Work Digital Toolkit for Employers on Workplace Health Checks and Opt-In HIV Testing. Int J Environ Res Public Health. 2020 Jan 6;17(1). pii: E379. doi: 10.3390/ijerph17010379. — View Citation

Blake H, Somerset S, Whittingham K, Middleton M, Yildirim M, Evans C. WHIRL Study: Workplace Health Interprofessional Learning in the Construction Industry. Int J Environ Res Public Health. 2020 Sep 18;17(18). pii: E6815. doi: 10.3390/ijerph17186815. — View Citation

Middleton M, Somerset S, Evans C, Blake H. Test@Work Texts: Mobile Phone Messaging to Increase Awareness of HIV and HIV Testing in UK Construction Employees during the COVID-19 Pandemic. Int J Environ Res Public Health. 2020 Oct 26;17(21). pii: E7819. doi — View Citation

Somerset S, Evans C, Blake H. Accessing Voluntary HIV Testing in the Construction Industry: A Qualitative Analysis of Employee Interviews from the Test@Work Study. Int J Environ Res Public Health. 2021 Apr 15;18(8). pii: 4184. doi: 10.3390/ijerph18084184. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Health check uptake Percentage of employees choosing to take a workplace health check from total employee population across all sites Rolling intervention delivery and data collection over 15 months
Secondary reasons for attending Qualitative data collected on reasons for opting in to health check immediately post-event
Secondary perceptions of employer's provision for health and wellbeing Qualitative data collected on perceptions towards employer immediately post-event
Secondary perceptions towards HIV testing in the workplace Qualitative data collected on employee views towards HIV testing at work immediately post-event
Secondary range of tests undertaken which of the optional checks/tests were taken by the employee during the health check, and qualitative data immediately post-event
Secondary Employee demographic profile Age, Gender, country of birth, ethnicity, postcode, sexual orientation, employment status (full-time or part-time, permanent, agency, contract worker) At recruitment
See also
  Status Clinical Trial Phase
Recruiting NCT06162897 - Case Management Dyad N/A
Completed NCT03999411 - Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients Phase 4
Completed NCT02528773 - Efficacy of ART to Interrupt HIV Transmission Networks
Active, not recruiting NCT05454839 - Preferences for Services in a Patient's First Six Months on Antiretroviral Therapy for HIV in South Africa
Recruiting NCT05322629 - Stepped Care to Optimize PrEP Effectiveness in Pregnant and Postpartum Women N/A
Completed NCT02579135 - Reducing HIV Risk Among Adolescents: Evaluating Project HEART N/A
Active, not recruiting NCT01790373 - Evaluating a Youth-Focused Economic Empowerment Approach to HIV Treatment Adherence N/A
Not yet recruiting NCT06044792 - The Influence of Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction in PLWH
Completed NCT04039217 - Antiretroviral Therapy (ART) Persistence in Different Body Compartments in HIV Negative MSM Phase 4
Active, not recruiting NCT04519970 - Clinical Opportunities and Management to Exploit Biktarvy as Asynchronous Connection Key (COMEBACK) N/A
Completed NCT04124536 - Combination Partner HIV Testing Strategies for HIV-positive and HIV-negative Pregnant Women N/A
Recruiting NCT05599581 - Tu'Washindi RCT: Adolescent Girls in Kenya Taking Control of Their Health N/A
Active, not recruiting NCT04588883 - Strengthening Families Living With HIV in Kenya N/A
Completed NCT02758093 - Speed of Processing Training in Adults With HIV N/A
Completed NCT02500446 - Dolutegravir Impact on Residual Replication Phase 4
Completed NCT03805451 - Life Steps for PrEP for Youth N/A
Active, not recruiting NCT03902431 - Translating the ABCS Into HIV Care N/A
Completed NCT00729391 - Women-Focused HIV Prevention in the Western Cape Phase 2/Phase 3
Recruiting NCT05736588 - Elimisha HPV (Human Papillomavirus) N/A
Recruiting NCT03589040 - Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant Phase 2

External Links